AU2014209177C1 - Paranasal sinus access implant devices and related tools, methods and kits - Google Patents
Paranasal sinus access implant devices and related tools, methods and kits Download PDFInfo
- Publication number
- AU2014209177C1 AU2014209177C1 AU2014209177A AU2014209177A AU2014209177C1 AU 2014209177 C1 AU2014209177 C1 AU 2014209177C1 AU 2014209177 A AU2014209177 A AU 2014209177A AU 2014209177 A AU2014209177 A AU 2014209177A AU 2014209177 C1 AU2014209177 C1 AU 2014209177C1
- Authority
- AU
- Australia
- Prior art keywords
- implant device
- conduit
- millimeters
- fistula
- millimeter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007943 implant Substances 0.000 title claims abstract description 382
- 210000003695 paranasal sinus Anatomy 0.000 title claims abstract description 110
- 238000000034 method Methods 0.000 title claims abstract description 59
- 206010016717 Fistula Diseases 0.000 claims abstract description 155
- 230000003890 fistula Effects 0.000 claims abstract description 155
- 239000012530 fluid Substances 0.000 claims abstract description 118
- 238000002513 implantation Methods 0.000 claims abstract description 99
- 210000001519 tissue Anatomy 0.000 claims abstract description 77
- 210000004561 lacrimal apparatus Anatomy 0.000 claims abstract description 51
- 238000004891 communication Methods 0.000 claims abstract description 8
- 238000011282 treatment Methods 0.000 claims description 64
- 210000003128 head Anatomy 0.000 claims description 62
- 239000000203 mixture Substances 0.000 claims description 51
- 238000004873 anchoring Methods 0.000 claims description 25
- 239000000463 material Substances 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 16
- 238000003780 insertion Methods 0.000 claims description 14
- 230000037431 insertion Effects 0.000 claims description 14
- 238000000926 separation method Methods 0.000 claims description 10
- 201000009890 sinusitis Diseases 0.000 claims description 6
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims description 5
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 5
- 230000002262 irrigation Effects 0.000 claims description 4
- 238000003973 irrigation Methods 0.000 claims description 4
- 230000001681 protective effect Effects 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 230000000843 anti-fungal effect Effects 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 210000003630 histaminocyte Anatomy 0.000 claims description 3
- 229960003444 immunosuppressant agent Drugs 0.000 claims description 3
- 239000003018 immunosuppressive agent Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 230000000510 mucolytic effect Effects 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 150000003431 steroids Chemical class 0.000 claims description 3
- 239000005526 vasoconstrictor agent Substances 0.000 claims description 3
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims description 2
- 230000001387 anti-histamine Effects 0.000 claims description 2
- 230000000840 anti-viral effect Effects 0.000 claims description 2
- 239000000739 antihistaminic agent Substances 0.000 claims description 2
- 230000001861 immunosuppressant effect Effects 0.000 claims description 2
- 210000001180 ethmoid sinus Anatomy 0.000 description 26
- 210000000988 bone and bone Anatomy 0.000 description 11
- 210000004083 nasolacrimal duct Anatomy 0.000 description 11
- 210000004086 maxillary sinus Anatomy 0.000 description 10
- 230000005540 biological transmission Effects 0.000 description 9
- 210000000826 nictitating membrane Anatomy 0.000 description 9
- 210000005252 bulbus oculi Anatomy 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 7
- 210000001214 frontal sinus Anatomy 0.000 description 6
- 210000003928 nasal cavity Anatomy 0.000 description 6
- 238000010276 construction Methods 0.000 description 5
- 210000003718 sphenoid sinus Anatomy 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 description 3
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 3
- 210000000795 conjunctiva Anatomy 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 206010009137 Chronic sinusitis Diseases 0.000 description 2
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- 108010093965 Polymyxin B Proteins 0.000 description 2
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- ZBPLOVFIXSTCRZ-UHFFFAOYSA-N bromfenac Chemical compound NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1 ZBPLOVFIXSTCRZ-UHFFFAOYSA-N 0.000 description 2
- 208000027157 chronic rhinosinusitis Diseases 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 210000001031 ethmoid bone Anatomy 0.000 description 2
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- DMKSVUSAATWOCU-HROMYWEYSA-N loteprednol etabonate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)OCCl)(OC(=O)OCC)[C@@]1(C)C[C@@H]2O DMKSVUSAATWOCU-HROMYWEYSA-N 0.000 description 2
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 2
- 235000010298 natamycin Nutrition 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- QEFAQIPZVLVERP-UHFFFAOYSA-N nepafenac Chemical compound NC(=O)CC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1N QEFAQIPZVLVERP-UHFFFAOYSA-N 0.000 description 2
- 229920000024 polymyxin B Polymers 0.000 description 2
- 229960005266 polymyxin b Drugs 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229940071643 prefilled syringe Drugs 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- BYJAVTDNIXVSPW-UHFFFAOYSA-N tetryzoline Chemical compound N1CCN=C1C1C2=CC=CC=C2CCC1 BYJAVTDNIXVSPW-UHFFFAOYSA-N 0.000 description 2
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 2
- VSQQQLOSPVPRAZ-RRKCRQDMSA-N trifluridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(C(F)(F)F)=C1 VSQQQLOSPVPRAZ-RRKCRQDMSA-N 0.000 description 2
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 1
- PDNHLCRMUIGNBV-UHFFFAOYSA-N 1-pyridin-2-ylethanamine Chemical compound CC(N)C1=CC=CC=N1 PDNHLCRMUIGNBV-UHFFFAOYSA-N 0.000 description 1
- KUGJPYZIWCRREB-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxoacetic acid Chemical compound OCC(N)(CO)CO.OC(=O)C(=O)NC1=CC(C#N)=CC(NC(=O)C(O)=O)=C1Cl KUGJPYZIWCRREB-UHFFFAOYSA-N 0.000 description 1
- PMQBICKXAAKXAY-HNCPQSOCSA-N 7-[(3r)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid;hydrochloride Chemical compound Cl.C1[C@H](N)CCCCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1Cl PMQBICKXAAKXAY-HNCPQSOCSA-N 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 108010026389 Gramicidin Proteins 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- LRJOMUJRLNCICJ-JZYPGELDSA-N Prednisolone acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O LRJOMUJRLNCICJ-JZYPGELDSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 229940019082 alaway Drugs 0.000 description 1
- 229940078679 alocril Drugs 0.000 description 1
- 229940066617 alomide Drugs 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 229960004024 besifloxacin Drugs 0.000 description 1
- QFFGVLORLPOAEC-SNVBAGLBSA-N besifloxacin Chemical compound C1[C@H](N)CCCCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1Cl QFFGVLORLPOAEC-SNVBAGLBSA-N 0.000 description 1
- 229940021570 besivance Drugs 0.000 description 1
- 229940041504 bromday Drugs 0.000 description 1
- 229960003655 bromfenac Drugs 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 229940088515 ciloxan Drugs 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 210000003717 douglas' pouch Anatomy 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 229940112573 elestat Drugs 0.000 description 1
- 238000011846 endoscopic investigation Methods 0.000 description 1
- 238000013129 endoscopic sinus surgery Methods 0.000 description 1
- WHWZLSFABNNENI-UHFFFAOYSA-N epinastine Chemical compound C1C2=CC=CC=C2C2CN=C(N)N2C2=CC=CC=C21 WHWZLSFABNNENI-UHFFFAOYSA-N 0.000 description 1
- 229940089062 eryped Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- NSYZCCDSJNWWJL-YXOIYICCSA-N erythromycin ethylsuccinate Chemical compound O1[C@H](C)C[C@H](N(C)C)[C@@H](OC(=O)CCC(=O)OCC)[C@@H]1O[C@H]1[C@@](O)(C)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(OC)C2)[C@@H]1C NSYZCCDSJNWWJL-YXOIYICCSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 229940124307 fluoroquinolone Drugs 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229960002963 ganciclovir Drugs 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 229960004905 gramicidin Drugs 0.000 description 1
- ZWCXYZRRTRDGQE-SORVKSEFSA-N gramicidina Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 ZWCXYZRRTRDGQE-SORVKSEFSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000004283 incisor Anatomy 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 229960004958 ketotifen Drugs 0.000 description 1
- 229960004305 lodoxamide Drugs 0.000 description 1
- RVGLGHVJXCETIO-UHFFFAOYSA-N lodoxamide Chemical compound OC(=O)C(=O)NC1=CC(C#N)=CC(NC(=O)C(O)=O)=C1Cl RVGLGHVJXCETIO-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940080267 lotemax Drugs 0.000 description 1
- 229960001798 loteprednol Drugs 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229960003702 moxifloxacin Drugs 0.000 description 1
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 description 1
- 229940066491 mucolytics Drugs 0.000 description 1
- 229960005016 naphazoline Drugs 0.000 description 1
- 229940099751 naphcon Drugs 0.000 description 1
- 229940064801 natacyn Drugs 0.000 description 1
- 229960003255 natamycin Drugs 0.000 description 1
- 239000004311 natamycin Substances 0.000 description 1
- 229960002259 nedocromil sodium Drugs 0.000 description 1
- JQEKDNLKIVGXAU-UHFFFAOYSA-L nedocromil sodium Chemical compound [Na+].[Na+].CCN1C(C([O-])=O)=CC(=O)C2=C1C(CCC)=C1OC(C([O-])=O)=CC(=O)C1=C2 JQEKDNLKIVGXAU-UHFFFAOYSA-L 0.000 description 1
- 229960001002 nepafenac Drugs 0.000 description 1
- 229940012664 nevanac Drugs 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 229960004114 olopatadine Drugs 0.000 description 1
- JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229940063161 pred forte Drugs 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940053174 restasis Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002474 sphenoid bone Anatomy 0.000 description 1
- 229960002673 sulfacetamide Drugs 0.000 description 1
- SKIVFJLNDNKQPD-UHFFFAOYSA-N sulfacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 SKIVFJLNDNKQPD-UHFFFAOYSA-N 0.000 description 1
- IHCDKJZZFOUARO-UHFFFAOYSA-M sulfacetamide sodium Chemical compound O.[Na+].CC(=O)[N-]S(=O)(=O)C1=CC=C(N)C=C1 IHCDKJZZFOUARO-UHFFFAOYSA-M 0.000 description 1
- 229960000654 sulfafurazole Drugs 0.000 description 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 1
- 229950006904 sulfisoxazole acetyl Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 238000007460 surgical drainage Methods 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229960000337 tetryzoline Drugs 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- 229940035275 tobrex Drugs 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 229960003962 trifluridine Drugs 0.000 description 1
- 229940099269 viroptic Drugs 0.000 description 1
- 229940020614 zirgan Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00772—Apparatus for restoration of tear ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M3/00—Medical syringes, e.g. enemata; Irrigators
- A61M3/02—Enemata; Irrigators
- A61M3/0233—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/24—Surgical instruments, devices or methods for use in the oral cavity, larynx, bronchial passages or nose; Tongue scrapers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0681—Sinus (maxillaris)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pulmonology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361757046P | 2013-01-25 | 2013-01-25 | |
| US61/757,046 | 2013-01-25 | ||
| US201361891250P | 2013-10-15 | 2013-10-15 | |
| US61/891,250 | 2013-10-15 | ||
| PCT/US2014/012995 WO2014116980A1 (en) | 2013-01-25 | 2014-01-24 | Paranasal sinus access implant devices and related tools, methods and kits |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2014209177A1 AU2014209177A1 (en) | 2015-08-06 |
| AU2014209177B2 AU2014209177B2 (en) | 2018-10-18 |
| AU2014209177C1 true AU2014209177C1 (en) | 2019-01-24 |
Family
ID=50116160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014209177A Active AU2014209177C1 (en) | 2013-01-25 | 2014-01-24 | Paranasal sinus access implant devices and related tools, methods and kits |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9561350B2 (enExample) |
| EP (2) | EP2903575B1 (enExample) |
| JP (1) | JP6246835B2 (enExample) |
| KR (1) | KR102189608B1 (enExample) |
| CN (1) | CN104968306B (enExample) |
| AU (1) | AU2014209177C1 (enExample) |
| BR (1) | BR112015017356B1 (enExample) |
| CA (1) | CA2892322C (enExample) |
| DK (1) | DK2903575T3 (enExample) |
| ES (1) | ES2652298T3 (enExample) |
| MX (1) | MX365304B (enExample) |
| PT (1) | PT2903575T (enExample) |
| WO (1) | WO2014116980A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9022967B2 (en) | 2010-10-08 | 2015-05-05 | Sinopsys Surgical, Inc. | Implant device, tool, and methods relating to treatment of paranasal sinuses |
| WO2015069433A1 (en) | 2013-10-16 | 2015-05-14 | Sinopsys Surgical, Inc. | Apparatuses, tools and kits relating to fluid manipulation treatments of paranasal sinuses |
| JP2017522122A (ja) | 2014-07-24 | 2017-08-10 | シノプシス サージカル インコーポレイテッドＳｉｎｏｐｓｙｓ Ｓｕｒｇｉｃａｌ，Ｉｎｃ． | 副鼻腔アクセスインプラントデバイスおよび関連する製品ならびに方法 |
| FI3675780T3 (fi) * | 2017-09-20 | 2025-03-13 | Sinopsys Surgical Inc | Paranasaaliseen sinukseen nestepääsyn mahdollistavia implantointityökaluja ja -kokoonpanoja |
| US12059558B2 (en) * | 2019-06-07 | 2024-08-13 | Medtronic, Inc. | Shield optimization for maximizing heat dissipation at the device tissue interface and improving fixation |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060276738A1 (en) * | 2005-06-06 | 2006-12-07 | Becker Bruce B | Lacrimal drainage bypass device and method |
| US20090104248A1 (en) * | 2007-09-07 | 2009-04-23 | Qlt Plug Delivery, Inc. -Qpdi | Lacrimal implants and related methods |
| US20120089071A1 (en) * | 2010-10-08 | 2012-04-12 | DCS Surgical,.Inc. | Implant device, tool, and methods relating to treatment of paranasal sinuses |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3726284A (en) | 1971-04-05 | 1973-04-10 | R Parker | Replacement tube for the lacrimal drainage ducts |
| US3948272A (en) | 1975-04-08 | 1976-04-06 | Procedure Medical Products, Inc. | Reconstruction device for lacrimal drainage ducts |
| US4915684A (en) | 1988-06-21 | 1990-04-10 | Mackeen Donald L | Method and apparatus for modulating the flow of lacrimal fluid through a punctum and associated canaliculus |
| US4921485A (en) | 1988-09-28 | 1990-05-01 | Griffiths John D | Catheter for use in the surgical correction of a nasolacrimal duct obstruction |
| US5169386A (en) | 1989-09-11 | 1992-12-08 | Bruce B. Becker | Method and catheter for dilatation of the lacrimal system |
| US5345948A (en) | 1993-04-08 | 1994-09-13 | Donnell Jr Francis E O | Method of performing translactrimal laser dacryocystorhinostomy |
| EP0631793A1 (en) | 1993-06-30 | 1995-01-04 | Cook Incorporated | Splittable hemostatic valve and method of use with a splittable introducer sheath |
| US6406453B1 (en) | 1995-04-26 | 2002-06-18 | Medtronic Xomed, Inc. | Composite ventilation tube |
| US6041785A (en) | 1997-03-27 | 2000-03-28 | Eaglevision, Inc. | Punctum plug |
| US6083188A (en) | 1998-02-04 | 2000-07-04 | Becker; Bruce B. | Lacrimal silicone stent with very large diameter segment insertable transnasally |
| US8007498B2 (en) | 1999-12-09 | 2011-08-30 | Mische Hans A | Methods and devices for treatment of bone fractures |
| US9351772B2 (en) | 1999-12-09 | 2016-05-31 | Hans A. Mische | Method and devices for the treatment of nasal sinus disorders |
| CN100418497C (zh) | 2000-03-14 | 2008-09-17 | 中川皓夫 | 泪道再造手术中使用的鼻泪管软管以及鼻泪管软管器具 |
| US6629533B1 (en) * | 2000-06-30 | 2003-10-07 | Eagle Vision, Inc. | Punctum plug with at least one anchoring arm |
| FR2813522B1 (fr) | 2000-09-06 | 2003-08-08 | Alain Fouere | Dispositif de drain lacrymal maintenu en place grace a un filetage externe |
| DE10105592A1 (de) | 2001-02-06 | 2002-08-08 | Achim Goepferich | Platzhalter zur Arzneistofffreigabe in der Stirnhöhle |
| US6966888B2 (en) | 2002-01-13 | 2005-11-22 | Eagle Vision, Inc. | Sinus valved glaucoma shunt |
| WO2003099175A1 (en) | 2002-05-29 | 2003-12-04 | University Of Saskatchewan Technologies Inc. | A shunt and method treatment of glaucoma |
| US7169163B2 (en) | 2002-09-30 | 2007-01-30 | Bruce Becker | Transnasal method and catheter for lacrimal system |
| EP1415671A1 (en) | 2002-11-01 | 2004-05-06 | Polyganics B.V. | Biodegradable drains for medical applications |
| CA2518960C (en) | 2003-03-14 | 2013-08-27 | Sinexus, Inc. | Sinus delivery of sustained release therapeutics |
| US20040204704A1 (en) | 2003-04-10 | 2004-10-14 | Ceramoptec Industries, Inc. | Device and method for dacryocystorhinostomy |
| US6994684B2 (en) * | 2003-06-16 | 2006-02-07 | Alphamed Inc. | Punctum plugs having fluid collecting recesses and methods of punctal occlusion |
| WO2005051473A2 (en) | 2003-11-26 | 2005-06-09 | Sinu Shunt A/S | Shunt system with coating and flow restricting component exerting a passive and essentially constant resistance to outflow |
| US20050197614A1 (en) | 2004-03-04 | 2005-09-08 | Wilson Pritchard | Occlusive biomedical devices, punctum plugs, and methods of use thereof |
| US8764729B2 (en) | 2004-04-21 | 2014-07-01 | Acclarent, Inc. | Frontal sinus spacer |
| US7720521B2 (en) | 2004-04-21 | 2010-05-18 | Acclarent, Inc. | Methods and devices for performing procedures within the ear, nose, throat and paranasal sinuses |
| US7803150B2 (en) | 2004-04-21 | 2010-09-28 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
| US7654997B2 (en) | 2004-04-21 | 2010-02-02 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat |
| US8894614B2 (en) | 2004-04-21 | 2014-11-25 | Acclarent, Inc. | Devices, systems and methods useable for treating frontal sinusitis |
| US9554691B2 (en) | 2004-04-21 | 2017-01-31 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
| US20060004323A1 (en) | 2004-04-21 | 2006-01-05 | Exploramed Nc1, Inc. | Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures |
| US9089258B2 (en) | 2004-04-21 | 2015-07-28 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
| US9101384B2 (en) | 2004-04-21 | 2015-08-11 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat |
| US8747389B2 (en) | 2004-04-21 | 2014-06-10 | Acclarent, Inc. | Systems for treating disorders of the ear, nose and throat |
| US7419497B2 (en) | 2004-04-21 | 2008-09-02 | Acclarent, Inc. | Methods for treating ethmoid disease |
| US7410480B2 (en) | 2004-04-21 | 2008-08-12 | Acclarent, Inc. | Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders |
| US7361168B2 (en) | 2004-04-21 | 2008-04-22 | Acclarent, Inc. | Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders |
| US20070208252A1 (en) | 2004-04-21 | 2007-09-06 | Acclarent, Inc. | Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses |
| US7462175B2 (en) | 2004-04-21 | 2008-12-09 | Acclarent, Inc. | Devices, systems and methods for treating disorders of the ear, nose and throat |
| US8146400B2 (en) | 2004-04-21 | 2012-04-03 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
| US20070167682A1 (en) | 2004-04-21 | 2007-07-19 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
| US20110004057A1 (en) | 2004-04-21 | 2011-01-06 | Acclarent, Inc. | Systems and methods for transnasal dilation of passageways in the ear, nose or throat |
| US20060063973A1 (en) | 2004-04-21 | 2006-03-23 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear, nose and throat |
| US9351750B2 (en) | 2004-04-21 | 2016-05-31 | Acclarent, Inc. | Devices and methods for treating maxillary sinus disease |
| US9399121B2 (en) | 2004-04-21 | 2016-07-26 | Acclarent, Inc. | Systems and methods for transnasal dilation of passageways in the ear, nose or throat |
| US7559925B2 (en) | 2006-09-15 | 2009-07-14 | Acclarent Inc. | Methods and devices for facilitating visualization in a surgical environment |
| US8414473B2 (en) | 2004-04-21 | 2013-04-09 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear nose and throat |
| US7156821B2 (en) | 2004-04-23 | 2007-01-02 | Massachusetts Eye & Ear Infirmary | Shunt with enclosed pressure-relief valve |
| US9452133B2 (en) | 2005-04-25 | 2016-09-27 | KEM Patent Holdings, LLC | Method for preventing nasolacrimal duct obstruction |
| USD590935S1 (en) | 2005-06-06 | 2009-04-21 | Becker Bruce B | Lacrimal drainage tube |
| US8951225B2 (en) | 2005-06-10 | 2015-02-10 | Acclarent, Inc. | Catheters with non-removable guide members useable for treatment of sinusitis |
| US20070005120A1 (en) | 2005-06-30 | 2007-01-04 | Equipsa S.A. | Method of intracanalicular laser dacryocystorhinostomy |
| ES2640458T3 (es) | 2006-03-31 | 2017-11-03 | Mati Therapeutics Inc. | Implantes del sistema de drenaje nasolagrimal para terapia medicamentosa |
| US7520876B2 (en) | 2006-04-21 | 2009-04-21 | Entellus Medical, Inc. | Device and method for treatment of sinusitis |
| JP5124721B2 (ja) | 2006-04-27 | 2013-01-23 | 医療法人 すぎもと眼科医院 | 涙道治療用具 |
| US20070276314A1 (en) | 2006-05-26 | 2007-11-29 | Becker Bruce B | Nasolacrimal duct probing, intubating and irrigating device |
| CA2659829A1 (en) | 2006-05-26 | 2007-12-06 | Bruce B. Becker | Nasolacrimal system surgical tool and method |
| US7547323B2 (en) | 2006-08-29 | 2009-06-16 | Sinexus, Inc. | Stent for irrigation and delivery of medication |
| US9820688B2 (en) | 2006-09-15 | 2017-11-21 | Acclarent, Inc. | Sinus illumination lightwire device |
| GB2442205B (en) | 2006-09-29 | 2008-11-05 | Andrew Robert Pearson | Improved tear-duct drain |
| WO2008124787A2 (en) | 2007-04-09 | 2008-10-16 | Acclarent, Inc. | Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis |
| KR20100058620A (ko) | 2007-09-07 | 2010-06-03 | 큐엘티 플러그 딜리버리, 인코포레이티드 | 눈물 임플랜트용 삽입 및 적출 기구 |
| NZ598483A (en) | 2007-09-07 | 2013-08-30 | Quadra Logic Tech Inc | Drug cores for sustained release of therapeutic agents |
| CN102112076B (zh) * | 2007-09-07 | 2015-04-22 | 马缇医疗股份有限公司 | 泪腺植入物及相关方法 |
| EP3372205A1 (en) | 2007-09-07 | 2018-09-12 | Mati Therapeutics Inc. | Lacrimal implant detection |
| JP5552482B2 (ja) | 2008-04-30 | 2014-07-16 | キュー エル ティー インク． | 複合涙管挿入物および関連する方法 |
| US7846124B2 (en) | 2008-05-07 | 2010-12-07 | Becker Bruce B | Punctal anchor for lacrimal stent, introducer tool and method |
| US8210902B2 (en) | 2008-05-30 | 2012-07-03 | Qlt Inc. | Surface treated implantable articles and related methods |
| US20100076269A1 (en) | 2008-09-18 | 2010-03-25 | Acclarent, Inc. | Systems and Methods for Treating Sinuses |
| US20100106255A1 (en) | 2008-10-24 | 2010-04-29 | Dubin Marc G | Self-expanding frontal sinus stent and insertion tool |
| KR20110132369A (ko) * | 2009-02-23 | 2011-12-07 | 큐엘티 인코포레이티드 | 눈물 임플란트 및 관련 방법 |
| EP2410959B1 (en) | 2009-03-26 | 2014-06-11 | Abbott Medical Optics Inc. | Glaucoma shunts with flow management and improved surgical performance |
| CA2781629A1 (en) | 2009-11-27 | 2011-06-03 | Sascha K. Zarins | Lacrimal implants including split and insertable drug core |
| US9510857B2 (en) | 2010-03-10 | 2016-12-06 | Boston Scientific Neuromodulation Corporation | System and method for making and using a lead introducer for an implantable electrical stimulation system |
| US8998985B2 (en) | 2011-07-25 | 2015-04-07 | Rainbow Medical Ltd. | Sinus stent |
| JP2015509786A (ja) | 2012-02-29 | 2015-04-02 | サイナシス コーポレーション | 副鼻腔開口部を拡張して副鼻腔炎を治療するためのデバイスおよび方法 |
| US9572964B2 (en) | 2012-04-11 | 2017-02-21 | Sinapsys Surgical, Inc. | Implantation tools, tool assemblies, kits and methods |
| WO2014078288A1 (en) * | 2012-11-14 | 2014-05-22 | Transcend Medical, Inc. | Flow promoting ocular implant |
-
2014
- 2014-01-24 BR BR112015017356-0A patent/BR112015017356B1/pt active IP Right Grant
- 2014-01-24 JP JP2015555352A patent/JP6246835B2/ja active Active
- 2014-01-24 KR KR1020157015175A patent/KR102189608B1/ko active Active
- 2014-01-24 US US14/424,841 patent/US9561350B2/en active Active
- 2014-01-24 PT PT147052377T patent/PT2903575T/pt unknown
- 2014-01-24 CN CN201480006189.3A patent/CN104968306B/zh active Active
- 2014-01-24 AU AU2014209177A patent/AU2014209177C1/en active Active
- 2014-01-24 WO PCT/US2014/012995 patent/WO2014116980A1/en not_active Ceased
- 2014-01-24 EP EP14705237.7A patent/EP2903575B1/en active Active
- 2014-01-24 MX MX2015009603A patent/MX365304B/es active IP Right Grant
- 2014-01-24 DK DK14705237.7T patent/DK2903575T3/en active
- 2014-01-24 EP EP17189916.4A patent/EP3281612B1/en active Active
- 2014-01-24 ES ES14705237.7T patent/ES2652298T3/es active Active
- 2014-01-24 CA CA2892322A patent/CA2892322C/en active Active
-
2017
- 2017-02-06 US US15/424,999 patent/US20170209678A1/en not_active Abandoned
-
2018
- 2018-11-13 US US16/189,465 patent/US20190175882A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060276738A1 (en) * | 2005-06-06 | 2006-12-07 | Becker Bruce B | Lacrimal drainage bypass device and method |
| US20090104248A1 (en) * | 2007-09-07 | 2009-04-23 | Qlt Plug Delivery, Inc. -Qpdi | Lacrimal implants and related methods |
| US20120089071A1 (en) * | 2010-10-08 | 2012-04-12 | DCS Surgical,.Inc. | Implant device, tool, and methods relating to treatment of paranasal sinuses |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3281612A1 (en) | 2018-02-14 |
| ES2652298T3 (es) | 2018-02-01 |
| US9561350B2 (en) | 2017-02-07 |
| JP6246835B2 (ja) | 2017-12-13 |
| JP2016504163A (ja) | 2016-02-12 |
| AU2014209177B2 (en) | 2018-10-18 |
| EP2903575A1 (en) | 2015-08-12 |
| KR20150110479A (ko) | 2015-10-02 |
| US20150231376A1 (en) | 2015-08-20 |
| DK2903575T3 (en) | 2018-01-22 |
| AU2014209177A1 (en) | 2015-08-06 |
| HK1212193A1 (en) | 2016-06-10 |
| US20170209678A1 (en) | 2017-07-27 |
| BR112015017356B1 (pt) | 2022-02-08 |
| BR112015017356A2 (pt) | 2017-07-11 |
| US20190175882A1 (en) | 2019-06-13 |
| EP2903575B1 (en) | 2017-11-22 |
| MX2015009603A (es) | 2016-04-06 |
| EP3281612B1 (en) | 2020-04-22 |
| WO2014116980A1 (en) | 2014-07-31 |
| CN104968306A (zh) | 2015-10-07 |
| PT2903575T (pt) | 2018-01-08 |
| CA2892322C (en) | 2017-05-30 |
| CN104968306B (zh) | 2018-09-25 |
| MX365304B (es) | 2019-05-29 |
| CA2892322A1 (en) | 2014-07-31 |
| KR102189608B1 (ko) | 2020-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10940297B2 (en) | Method for providing access to a paranasal sinus | |
| US20190175882A1 (en) | Paranasal sinus access implant devices and related tools, methods and kits | |
| EP3057549B1 (en) | Apparatuses, tools and kits relating to fluid manipulation treatments of paranasal sinuses | |
| HK1212193B (en) | Paranasal sinus access implant device and kit | |
| HK1187559B (en) | Implant device and tool | |
| HK1187559A (en) | Implant device and tool |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 17 OCT 2018 |
|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT FILED 17 OCT 2018 |
|
| FGA | Letters patent sealed or granted (standard patent) |